(3) Given that ER signaling regulates a number of critical pathways in tumor growth/development, genome wide analysis of ER target genes in palbociclib-treated MCF-7/C and MCF-7/FGFR1 cells may identify more mediators of the resistance. This evidence concerns the gene ESR1 and neoplasm.